Literature DB >> 22405748

An outbreak of human parainfluenza virus 3 infection in an outpatient hematopoietic stem cell transplantation clinic.

Emily R M Sydnor1, Amy Greer, Alicia P Budd, Miriana Pehar, Supriya Munshaw, Dionissios Neofytos, Trish M Perl, Alexandra Valsamakis.   

Abstract

BACKGROUND: Parainfluenza viruses cause respiratory tract infections in adults and children, with peak activity during the spring and summer months. Human parainfluenza virus type 3 (hPIV-3) can contribute to significant morbidity and mortality in patients undergoing hematopoietic stem cell transplantation (HSCT).
METHODS: Automated surveillance software was used to identify an hPIV-3 outbreak in an HSCT clinic. Active surveillance for respiratory illness and infection control measures were instituted. A retrospective molecular investigation of outbreak viral strains was performed by direct sequencing.
RESULTS: Twelve of 196 HSCT recipients attending the clinic during the outbreak period had hPIV-3; one of these patients died. Sequencing demonstrated highly related strains in 9 of 10 patients studied. Despite the ongoing presence of hPIV-3 outside the inpatient/outpatient care continuum clinic, only 2 cases were observed after institution of respiratory season infection control measures.
CONCLUSIONS: This investigation demonstrates the utility of surveillance software in the identification of respiratory virus outbreaks and the importance of rapid implementation of infection control/prevention measures for containment of outbreaks.
Copyright © 2012 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22405748     DOI: 10.1016/j.ajic.2011.11.011

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  12 in total

1.  Characterizing the Cellular Immune Response to Parainfluenza Virus 3.

Authors:  Paibel I Aguayo-Hiraldo; Reuben J Arasaratnam; Ifigeneia Tzannou; Manik Kuvalekar; Premal Lulla; Swati Naik; Caridad A Martinez; Pedro A Piedra; Juan F Vera; Ann M Leen
Journal:  J Infect Dis       Date:  2017-07-15       Impact factor: 5.226

2.  Blood and marrow transplant clinical trials network state of the Science Symposium 2014.

Authors:  Frederick R Appelbaum; Claudio Anasetti; Joseph H Antin; Harold Atkins; Stella Davies; Steven Devine; Sergio Giralt; Helen Heslop; Ginna Laport; Stephanie J Lee; Brent Logan; Marcelo Pasquini; Michael Pulsipher; Edward Stadtmauer; John R Wingard; Mary M Horowitz
Journal:  Biol Blood Marrow Transplant       Date:  2014-10-15       Impact factor: 5.742

3.  Cholesterol reducing agents inhibit assembly of type I parainfluenza viruses.

Authors:  Shringkhala Bajimaya; Tsuyoshi Hayashi; Tünde Frankl; Peter Bryk; Brian Ward; Toru Takimoto
Journal:  Virology       Date:  2016-12-02       Impact factor: 3.616

4.  Parainfluenza virus type 3 Ab in allogeneic hematopoietic cell transplant recipients: factors influencing post-transplant Ab titers and associated outcomes.

Authors:  S Seo; H Xie; R A Karron; B Thumar; J A Englund; W M Leisenring; T Stevens-Ayers; M Boeckh; A P Campbell
Journal:  Bone Marrow Transplant       Date:  2014-06-30       Impact factor: 5.483

Review 5.  Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus.

Authors:  Hans H Hirsch; Rodrigo Martino; Katherine N Ward; Michael Boeckh; Hermann Einsele; Per Ljungman
Journal:  Clin Infect Dis       Date:  2012-09-28       Impact factor: 9.079

6.  Nosocomial transmission of respiratory syncytial virus in an outpatient cancer center.

Authors:  Helen Y Chu; Janet A Englund; Sara Podczervinski; Jane Kuypers; Angela P Campbell; Michael Boeckh; Steven A Pergam; Corey Casper
Journal:  Biol Blood Marrow Transplant       Date:  2014-03-06       Impact factor: 5.742

7.  Universal Mask Usage for Reduction of Respiratory Viral Infections After Stem Cell Transplant: A Prospective Trial.

Authors:  Anthony D Sung; Julia A M Sung; Samantha Thomas; Terry Hyslop; Cristina Gasparetto; Gwynn Long; David Rizzieri; Keith M Sullivan; Kelly Corbet; Gloria Broadwater; Nelson J Chao; Mitchell E Horwitz
Journal:  Clin Infect Dis       Date:  2016-08-01       Impact factor: 9.079

8.  Community-Acquired Respiratory Viruses in Oncology: Lessons to Be Learnt from the SARS-CoV-2 Pandemic.

Authors:  Marie von Lilienfeld-Toal
Journal:  Oncol Res Treat       Date:  2020-05-14       Impact factor: 2.825

9.  Multiplex real-time PCR for prompt diagnosis of an outbreak of human parainfluenza 3 virus in children with acute leukemia.

Authors:  R Berrueco; A Antón; S Rives; A Català; T Toll; A Ruiz; M Camós; M Torrebadell; J Estella; C Muñoz-Almagro
Journal:  Infection       Date:  2013-07-03       Impact factor: 3.553

10.  Human parainfluenza virus in patients with influenza-like illness from Central and South America during 2006-2010.

Authors:  Manuel V Villaran; Josefina García; Jorge Gomez; Ana E Arango; Marina Gonzales; Wilson Chicaiza; Washington Alemán; Ivette Lorenzana de Rivera; Felix Sanchez; Nicolas Aguayo; Tadeusz J Kochel; Eric S Halsey
Journal:  Influenza Other Respir Viruses       Date:  2013-11-28       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.